Previous studies by Wang et al. in patients with chronic hepatitis B showed a reduction of PD-1 and Tim-3 expressions on CD8+ T cells following antiviral treatment against HBV (43). This evidence concerns the gene CD8A and chronic hepatitis B virus infection.